Search results
Jonathan Zalevsky Sells 7,355 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
ETF DAILY NEWS· 3 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Jonathan Zalevsky sold 7,355 shares of the stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average ...
Tracking down the genetic causes of lupus to personalize treatment - Berkeley News
UC Berkeley NewsCenter· 1 day agoLupus is a lifelong, often painful and occasionally lethal autoimmune disease. Few treatments exist today beyond powerful steroids to knock down a patient’s immune system — a therapy that has ...
ADA2 regulates inflammation and hematopoietic stem cell emergence via the A2bR pathway in zebrafish...
Nature· 3 days agoA DADA2 zebrafish model with cecr1b deficiency was generated. Characterization of hematopoietic processes revealed a role of Cecr1b in regulating inflammation and hematopoietic stem cell production through the A2br-mediated adenosine signaling.
Cantor Fitzgerald Research Analysts Lower Earnings Estimates for Cabaletta Bio, Inc. (NASDAQ:CABA)
ETF DAILY NEWS· 5 days agoCabaletta Bio, Inc. (NASDAQ:CABA – Free Report) – Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of Cabaletta Bio in a note issued to investors on Thursday, May 16th. Cantor ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoRemeGen Completes Patient Enrollment in Two Phase III Clinical Trials Using Telitacicept for Treatment of IgA Nephropathy and Primary Sjögren's Syndrome PR Newswire YANTAI, China, May 21, 2024 YANTAI, China, May 21, 2024 /PRNewswire/ -- RemeGen
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
Zacks· 2 days agoFree Report) announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its lead pipeline candidate, Descartes-08, for the treatment of myasthenia gravis ...
Nightmares and hallucinations could signal autoimm | Newswise
Newswise· 4 days agoNewswise — (SACRAMENTO, Calif.) — An increase in nightmares and hallucinations could signal the onset of autoimmune diseases, such as lupus. The study was published in eClinicalMedicine, a publication of The Lancet.
Alpine Immune Sciences (NASDAQ:ALPN) Earns Neutral Rating from Wedbush
ETF DAILY NEWS· 6 days agoWedbush reaffirmed their neutral rating on shares of Alpine Immune Sciences (NASDAQ:ALPN – Free Report) in a research report report published on Thursday, Benzinga reports. They currently have ...
Howard W. Robin Sells 16,650 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
ETF DAILY NEWS· 3 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 16,650 shares of the company’s stock in a transaction on Friday, May 17th. Following the completion of the transaction ...